Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Christopher Darr"'
Autor:
Christopher Darr, Pedro Fragoso Costa, Theresa Kahl, Alexandros Moraitis, Jenna Engel, Mulham Al-Nader, Henning Reis, Jens Köllermann, Claudia Kesch, Ulrich Krafft, Tobias Maurer, Daniel Köhler, Susanne Klutmann, Fabian Falkenbach, Jens Kleesiek, Wolfgang P. Fendler, Boris A. Hadaschik, Ken Herrmann
Publikováno v:
European Urology Open Science, Vol 54, Iss , Pp 28-32 (2023)
In this prospective two-center feasibility study, we evaluate the diagnostic value of intraoperative ex vivo specimenPET/CT imaging of radical prostatectomy (RP) and lymphadenectomy specimens. Ten patients with high-risk prostate cancer underwent cli
Externí odkaz:
https://doaj.org/article/8a126cb7bf0b4692a6caa9dd993de240
Autor:
Stefanie Zschäbitz, Nadine Biernath, Thomas Hilser, Alexander Höllein, Friedemann Zengerling, Jozefina Cascucelli, Pia Paffenholz, Daniel Seidl, Christoph Lutz, Katrin Schlack, Dorothea Kingreen, Niklas Klümper, Philipp Ivanyi, Gunhild von Amsberg, Hendrik Heers, Florian Roghmann, Robert L. Tauber, Richard Cathomas, Luisa Hofer, Günter Niegisch, Melanie Klee, Roland Ehrenberg, Andreas Hassler, Boris A. Hadaschik, Viktor Grünwald, Christopher Darr
Publikováno v:
European Urology Open Science, Vol 53, Iss , Pp 31-37 (2023)
Background: Treatment options for patients with urothelial cancer (UC) refractory to platinum and immunotherapy are limited and survival is short. Enfortumab vedotin (EV) is a monoclonal anti-NECTIN4 antibody conjugated to monomethyl auristatin. It w
Externí odkaz:
https://doaj.org/article/bd7cfc5ca9a44412a57048e564c5b88c
Autor:
Nora Tabea Sibert, Tobias Kurth, Clara Breidenbach, Simone Wesselmann, Günther Feick, Ernst-Günter Carl, Sebastian Dieng, Mohamad Hatem Albarghouth, Atiqullah Aziz, Stefan Baltes, Elisabeth Bartolf, Jens Bedke, Andreas Blana, Marko Brock, Stefan Conrad, Christopher Darr, Florian Distler, Konstantinos Drosos, Gregor Duwe, Amr Gaber, Markus Giessing, Nina Natascha Harke, Axel Heidenreich, Sameh Hijazi, Andreas Hinkel, Björn Theodor Kaftan, Shatlyk Kheiderov, Thomas Knoll, Gerd Lümmen, Inga Peters, Bülent Polat, Valentin Schrodi, Jens-Uwe Stolzenburg, Zoltan Varga, Julius von Süßkind-Schwendi, Vahudin Zugor, Christoph Kowalski
Publikováno v:
PLoS ONE, Vol 18, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/5e3d756748774f7b862125818bea4512
Autor:
Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik, Viktor Grünwald
Publikováno v:
Cancers, Vol 15, Iss 2, p 461 (2023)
Androgen deprivation therapy (ADT) alone has been the standard of care for many years in men with metastatic prostate cancer. Due to the limited survival under this monotherapy, many new treatment options have been developed in the last few years. Re
Externí odkaz:
https://doaj.org/article/7d3ff6e9ee884a68bc5dbfeb1228529a
Autor:
Christoph Kowalski, Rebecca Roth, Günther Carl, Günter Feick, Alisa Oesterle, Andreas Hinkel, Thomas Steiner, Marko Brock, Björn Kaftan, Rainer Borowitz, Niko Zantl, Axel Heidenreich, Andreas Neisius, Christopher Darr, Christian Bolenz, Burkhard Beyer, Jesco Pfitzenmaier, Bernhard Brehmer, Jan Fichtner, Björn Haben, Simone Wesselmann, Sebastian Dieng
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-7 (2020)
Abstract Purpose To give an overview of the multicenter Prostate Cancer Outcomes (PCO) study, involving paper-based and web-based collection of patient-reported outcome measures (PROM) in patients undergoing local treatment for prostate cancer in cer
Externí odkaz:
https://doaj.org/article/9586a627a18248c28ed265e8de91dac2
Autor:
Ádám Széles, Petra Terézia Kovács, Anita Csizmarik, Melinda Váradi, Péter Riesz, Tamás Fazekas, Szilárd Váncsa, Péter Hegyi, Csilla Oláh, Stephan Tschirdewahn, Christopher Darr, Ulrich Krafft, Viktor Grünwald, Boris Hadaschik, Orsolya Horváth, Péter Nyirády, Tibor Szarvas
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2560 (2022)
Programmed death ligand-1 (PD-L1) is an immune checkpoint molecule and a widely used therapeutic target in urothelial cancer. Its circulating, soluble levels (sPD-L1) were recently suggested to be associated with the presence and prognosis of various
Externí odkaz:
https://doaj.org/article/f438f68b1e944c59a6bd8351a75b7323
Autor:
Andrej Panic, Henning Reis, Alina Wittka, Christopher Darr, Boris Hadaschik, Verena Jendrossek, Diana Klein
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Various types of human cancers were characterized by an altered expression of epithelial or stromal caveolin-1 (CAV1). However, the clinical significance of CAV1 expression in penile cancer remains largely unknown. Here the expression patterns of CAV
Externí odkaz:
https://doaj.org/article/520ee8bab8344bd5a93d0b65f52386cf
Autor:
Ulrich Krafft, Csilla Olah, Henning Reis, Claudia Kesch, Christopher Darr, Viktor Grünwald, Stephan Tschirdewahn, Boris Hadaschik, Orsolya Horvath, Istvan Kenessey, Peter Nyirady, Melinda Varadi, Orsolya Modos, Anita Csizmarik, Tibor Szarvas
Publikováno v:
Cancers, Vol 13, Iss 11, p 2548 (2021)
Serum PD-L1 (sPD-L1) levels are associated with prognosis in various tumors but has not yet been investigated in advanced bladder cancer. We assessed pretreatment serum samples from 83 BC patients who received platinum chemotherapy and from 12 patien
Externí odkaz:
https://doaj.org/article/0e56869ece3141718502a6f223926e56
Autor:
Yasemin Melisa Saner, Manuel Wiesenfarth, Vivienn Weru, Boris Ladyzhensky, Stephan Tschirdewahn, Lukas Püllen, David Bonekamp, Henning Reis, Ulrich Krafft, Jochen Heß, Claudia Kesch, Christopher Darr, Michael Forsting, Axel Wetter, Lale Umutlu, Johannes Haubold, Boris Hadaschik, Jan Philipp Radtke
Publikováno v:
European Urology Oncology. 6:49-55
Multiparametric magnetic resonance imaging (mpMRI) and targeted biopsy (TB) facilitate accurate detection of clinically significant prostate cancer (csPC). However, it remains unclear how targeted cores should be applied for accurate diagnosis of csP
Publikováno v:
Die Urologie. 61:1345-1350